Clinical features of three-dimensional computed tomography-based radiologic phenotypes of chronic obstructive pulmonary disease.
Aged
Aged, 80 and over
Airway Remodeling
Airway Resistance
Cluster Analysis
Cross-Sectional Studies
Dyspnea
/ diagnostic imaging
Female
Humans
Imaging, Three-Dimensional
Lung
/ diagnostic imaging
Male
Middle Aged
Phenotype
Predictive Value of Tests
Prognosis
Prospective Studies
Pulmonary Disease, Chronic Obstructive
/ diagnostic imaging
Pulmonary Emphysema
/ diagnostic imaging
Severity of Illness Index
Tomography, X-Ray Computed
airway
chronic obstructive pulmonary disease
clustering analysis
emphysema
phenotype
three-dimensional computed tomography
Journal
International journal of chronic obstructive pulmonary disease
ISSN: 1178-2005
Titre abrégé: Int J Chron Obstruct Pulmon Dis
Pays: New Zealand
ID NLM: 101273481
Informations de publication
Date de publication:
2019
2019
Historique:
received:
01
03
2019
accepted:
30
05
2019
entrez:
13
7
2019
pubmed:
13
7
2019
medline:
25
2
2020
Statut:
epublish
Résumé
The diagnosis and severity of chronic obstructive pulmonary disease (COPD) are defined by airflow limitation using spirometry. However, COPD has diverse clinical features, and several phenotypes based on non-spirometric data have been investigated. To identify novel phenotypes of COPD using radiologic data obtained by three-dimensional computed tomography (3D-CT). The inner luminal area and wall thickness of third- to sixth-generation bronchi and the percentage of the low-attenuation area (less than -950 HU) of the lungs were measured using 3D-CT in patients with COPD. Using the radiologic data, hierarchical clustering was performed. Respiratory reactance and resistance were measured to evaluate functional differences among the clusters. Four clusters were identified among 167 patients with COPD: Cluster I, mild emphysema with severe airway changes, severe airflow limitation, and high exacerbation risk; Cluster II, mild emphysema with moderate airway changes, mild airflow limitation, and mild dyspnea; Cluster III, severe emphysema with moderate airway changes, severe airflow limitation, and increased dyspnea; and Cluster IV, moderate emphysema with mild airway changes, mild airflow limitation, low exacerbation risk, and mild dyspnea. Cluster I had the highest respiratory resistance among the four clusters. Clusters I and III had higher respiratory reactance than Clusters II and IV. The 3D-CT-based radiologic phenotypes were associated with the clinical features of COPD. Measurement of respiratory resistance and reactance may help to identify phenotypic differences.
Identifiants
pubmed: 31296985
doi: 10.2147/COPD.S207267
pii: 207267
pmc: PMC6598936
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1333-1342Déclaration de conflit d'intérêts
Hiroshi Watanabe reports grants from Japan Agency for Medical Research and Development (AMED), and consulting and lectures fees from Nippon Shinyaku and Acterion. He also received lecture fees from Bayer and Pfizer, outside the submitted work. The authors report no other conflicts of interest in this work.
Références
N Engl J Med. 2010 Sep 16;363(12):1128-38
pubmed: 20843247
AJR Am J Roentgenol. 2010 Aug;195(2):363-9
pubmed: 20651191
AJR Am J Roentgenol. 2005 Dec;185(6):1509-15
pubmed: 16304005
Respir Med. 2014 Jan;108(1):136-43
pubmed: 24035313
Clin Imaging. 2010 May-Jun;34(3):172-8
pubmed: 20416480
J Allergy Clin Immunol. 2005 Oct;116(4):750-4
pubmed: 16210046
N Engl J Med. 2004 Jun 24;350(26):2645-53
pubmed: 15215480
Respir Med. 2008 Jan;102(1):42-9
pubmed: 17900886
Chest. 2018 Jan;153(1):65-76
pubmed: 28943279
Chest. 2004 May;125(5):1714-8
pubmed: 15136381
Respirology. 2006 Sep;11(5):579-85
pubmed: 16916330
Eur Respir J. 2010 Sep;36(3):531-9
pubmed: 20075045
Radiology. 2008 Sep;248(3):1042-9
pubmed: 18710993
Thorax. 2002 Mar;57(3):242-6
pubmed: 11867829
Chest. 2008 Dec;134(6):1183-1191
pubmed: 18641116
Respir Med. 2011 Mar;105(3):343-51
pubmed: 21074394
Thorax. 2015 Aug;70(8):725-31
pubmed: 26024687
Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):1102-8
pubmed: 10988137
Respirology. 2004 Aug;9(3):331-6
pubmed: 15363004
Radiology. 2011 Oct;261(1):274-82
pubmed: 21788524
Eur Respir J. 2003 Dec;22(6):1026-41
pubmed: 14680096
N Engl J Med. 2011 Oct 27;365(17):1567-75
pubmed: 22029978
COPD. 2011 Dec;8(6):456-63
pubmed: 22149407
N Engl J Med. 2004 Mar 4;350(10):1005-12
pubmed: 14999112
Ann Am Thorac Soc. 2015 Mar;12(3):303-12
pubmed: 25642832
Am J Respir Crit Care Med. 2010 Feb 15;181(4):353-9
pubmed: 19926869
Respiration. 2010;80(2):120-6
pubmed: 19776554
Clin Exp Allergy. 2018 Mar;48(3):278-287
pubmed: 29315896
Sci Rep. 2017 Aug 31;7(1):10187
pubmed: 28860527
Int J Chron Obstruct Pulmon Dis. 2011;6:551-61
pubmed: 22135488
Am J Respir Crit Care Med. 2006 Jun 15;173(12):1309-15
pubmed: 16556695
Sci Rep. 2017 Feb 08;7:41709
pubmed: 28176815
Eur Respir J. 2012 Aug;40(2):495-6
pubmed: 22855468
Radiology. 2005 Jun;235(3):1055-64
pubmed: 15833982
Pediatr Pulmonol. 2012 Jan;47(1):18-26
pubmed: 22170806
Thorax. 2015 Aug;70(8):719-24
pubmed: 26024690